| Uterine Corpus Neoplasm altered in cohorts of …ALTERED_INderived200 of 463show all (up to 200) |
|---|
| ← altered in cohorts of | TTN 297 / 559 cases (53 %) · ssm · TCGA-UCEC · largest of 6 cohorts | — | — | Endometrial Carcinoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | OBSCN 296 / 559 cases (53 %) · ssm · TCGA-UCEC · largest of 6 cohorts | — | — | Endometrial Carcinoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | RYR2 291 / 559 cases (52 %) · ssm · TCGA-UCEC · largest of 6 cohorts | — | — | Endometrial Carcinoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | ASH1L 289 / 559 cases (52 %) · ssm · TCGA-UCEC · largest of 6 cohorts | — | — | Endometrial Carcinoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | USH2A 286 / 559 cases (51 %) · ssm · TCGA-UCEC · largest of 6 cohorts | — | — | Endometrial Carcinoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | FLG 283 / 559 cases (51 %) · ssm · TCGA-UCEC · largest of 6 cohorts | — | — | Endometrial Carcinoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | CACNA1E 281 / 559 cases (50 %) · ssm · TCGA-UCEC · largest of 6 cohorts | — | — | Endometrial Carcinoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | PTEN 941 / 1,882 cases (50 %) · ssm · ucec_ancestry_cds_msk_2023 · largest of 12 cohorts | — | — | Endometrial Carcinoma | 12 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HMCN1 278 / 559 cases (50 %) · ssm · TCGA-UCEC · largest of 6 cohorts | — | — | Endometrial Carcinoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | CEP350 277 / 559 cases (50 %) · ssm · TCGA-UCEC · largest of 3 cohorts | — | — | Endometrial Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | CSMD3 277 / 559 cases (50 %) · ssm · TCGA-UCEC · largest of 6 cohorts | — | — | Endometrial Carcinoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | HRNR 277 / 559 cases (50 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ASPM 275 / 559 cases (49 %) · ssm · TCGA-UCEC · largest of 6 cohorts | — | — | Endometrial Carcinoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | GON4L 275 / 559 cases (49 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NFASC 271 / 559 cases (48 %) · ssm · TCGA-UCEC · largest of 4 cohorts | — | — | Endometrial Carcinoma | 4 | Observed | gdc | graph → |
| ← altered in cohorts of | CSMD1 270 / 559 cases (48 %) · ssm · TCGA-UCEC · largest of 6 cohorts | — | — | Endometrial Carcinoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | INSRR 269 / 559 cases (48 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PDE4DIP 269 / 559 cases (48 %) · ssm · TCGA-UCEC · largest of 2 cohorts | — | — | Endometrial Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | SPTA1 269 / 559 cases (48 %) · ssm · TCGA-UCEC · largest of 6 cohorts | — | — | Endometrial Carcinoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | SETDB1 267 / 559 cases (48 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COPA 266 / 559 cases (48 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | F5 266 / 559 cases (48 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MUC16 266 / 559 cases (48 %) · ssm · TCGA-UCEC · largest of 6 cohorts | — | — | Endometrial Carcinoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | ARHGEF2 265 / 559 cases (47 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRRC2C 265 / 559 cases (47 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LYST 264 / 559 cases (47 %) · ssm · TCGA-UCEC · largest of 6 cohorts | — | — | Endometrial Carcinoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | NES 264 / 559 cases (47 %) · ssm · TCGA-UCEC · largest of 2 cohorts | — | — | Endometrial Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | NUP210L 264 / 559 cases (47 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IGSF9 263 / 559 cases (47 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KIF26B 263 / 559 cases (47 %) · ssm · TCGA-UCEC · largest of 2 cohorts | — | — | Endometrial Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | PIK3C2B 263 / 559 cases (47 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POGZ 263 / 559 cases (47 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CACNA1S 262 / 559 cases (47 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FLG2 262 / 559 cases (47 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP1A2 261 / 559 cases (47 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KIF14 261 / 559 cases (47 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NAV1 261 / 559 cases (47 %) · ssm · TCGA-UCEC · largest of 2 cohorts | — | — | Endometrial Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | TG 261 / 559 cases (47 %) · ssm · TCGA-UCEC · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | gdc | graph → |
| ← altered in cohorts of | TCHH 260 / 559 cases (47 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARHGEF11 259 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARID4B 259 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KIF21B 259 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RUSC1 259 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF687 259 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADAMTSL4 258 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ASTN1 258 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CR1 258 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CRB1 258 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OLFML2B 258 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PAPPA2 258 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC9C2 258 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TPR 258 / 559 cases (46 %) · ssm · TCGA-UCEC · largest of 3 cohorts | — | — | Endometrial Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | BCL9 257 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CAMSAP2 257 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RPRD2 257 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEMA4A 257 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADCY10 256 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARHGAP30 256 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CENPF 256 / 559 cases (46 %) · ssm · TCGA-UCEC · largest of 2 cohorts | — | — | Endometrial Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | HEATR1 256 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KHDC4 256 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBTB41 256 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP1A4 255 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HYDIN 255 / 559 cases (46 %) · ssm · TCGA-UCEC · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | gdc | graph → |
| ← altered in cohorts of | IQGAP3 255 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PEAR1 255 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | STYXL2 255 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SV2A 255 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UBQLN4 255 / 559 cases (46 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | AHCTF1 254 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | AXDND1 254 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GJA8 254 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNT2 254 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OTUD7B 254 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCNX2 254 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PI4KB 254 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PKHD1L1 254 / 559 cases (45 %) · ssm · TCGA-UCEC · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | gdc | graph → |
| ← altered in cohorts of | TNR 254 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRIM46 254 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | YY1AP1 254 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZFHX4 254 / 559 cases (45 %) · ssm · TCGA-UCEC · largest of 6 cohorts | — | — | Endometrial Carcinoma | 6 | Observed | gdc | graph → |
| ← altered in cohorts of | CGN 253 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ITGA10 253 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MIA3 253 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRG4 253 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SIPA1L2 253 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | THBS3 253 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TP53 850 / 1,882 cases (45 %) · ssm · ucec_ancestry_cds_msk_2023 · largest of 15 cohorts | — | — | Endometrial Carcinoma | 15 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ATP2B4 252 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DENND4B 252 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DISP1 252 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LMNA 252 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RAB3GAP2 252 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RASAL2 252 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SUCO 252 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SYT11 252 / 559 cases (45 %) · ssm · TCGA-UCEC | — | — | Endometrial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PIK3CA 824 / 1,882 cases (44 %) · ssm · ucec_ancestry_cds_msk_2023 · largest of 15 cohorts | — | — | Endometrial Carcinoma | 15 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARID1A 793 / 1,882 cases (42 %) · ssm · ucec_ancestry_cds_msk_2023 · largest of 11 cohorts | — | — | Endometrial Carcinoma | 11 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FRG1BP 21 / 57 cases (37 %) · ssm · ucs_tcga | — | — | Uterine Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NOTCH3 53 / 181 cases (29 %) · ssm · ucec_ccr_msk_2022 · largest of 2 cohorts | — | — | Endometrial Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SMARCA4 48 / 181 cases (27 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | POLD1 47 / 180 cases (26 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PIK3R1 484 / 1,882 cases (26 %) · ssm · ucec_ancestry_cds_msk_2023 · largest of 10 cohorts | — | — | Endometrial Carcinoma | 10 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRS 46 / 181 cases (25 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | IRS2 45 / 181 cases (25 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CCND1 43 / 181 cases (24 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MSH3 40 / 169 cases (24 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC5B 117 / 517 cases (23 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MSH2 40 / 181 cases (22 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE1 114 / 517 cases (22 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CHD4 113 / 517 cases (22 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BRD4 39 / 181 cases (22 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MACF1 109 / 517 cases (21 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT4 108 / 517 cases (21 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NEB 106 / 517 cases (21 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTCH1 37 / 181 cases (20 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TSC1 37 / 181 cases (20 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TAF1 104 / 517 cases (20 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARHGAP35 103 / 517 cases (20 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DMD 103 / 517 cases (20 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH7 103 / 517 cases (20 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT1 103 / 517 cases (20 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 7 cohorts | — | — | Endometrial Carcinoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FLT4 36 / 181 cases (20 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | IRS1 36 / 181 cases (20 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCLO 102 / 517 cases (20 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR3 102 / 517 cases (20 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AHNAK2 100 / 517 cases (19 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH10 100 / 517 cases (19 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH5 100 / 517 cases (19 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT3 99 / 517 cases (19 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP1B 99 / 517 cases (19 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Endometrial Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KRAS 357 / 1,882 cases (19 %) · ssm · ucec_ancestry_cds_msk_2023 · largest of 9 cohorts | — | — | Endometrial Carcinoma | 9 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR1 98 / 517 cases (19 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KDM5C 34 / 181 cases (19 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NCOR1 34 / 181 cases (19 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRT 34 / 181 cases (19 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HUWE1 97 / 517 cases (19 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MDN1 96 / 517 cases (19 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANK3 95 / 517 cases (18 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DST 95 / 517 cases (18 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LATS2 33 / 181 cases (18 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TENM1 94 / 517 cases (18 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Endometrial Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ABCA13 93 / 517 cases (18 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT2 93 / 517 cases (18 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HERC2 93 / 517 cases (18 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP2 93 / 517 cases (18 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE2 93 / 517 cases (18 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF292 93 / 517 cases (18 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AHNAK 92 / 517 cases (18 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH11 92 / 517 cases (18 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Endometrial Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH8 92 / 517 cases (18 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MED12 92 / 517 cases (18 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Endometrial Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RPL22 89 / 511 cases (17 %) · ssm · ucec_tcga_gdc · largest of 3 cohorts | — | — | Endometrial Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LAMA2 90 / 517 cases (17 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC4 90 / 517 cases (17 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Endometrial Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP1 89 / 517 cases (17 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERBB3 31 / 181 cases (17 %) · ssm · ucec_ccr_msk_2022 · largest of 2 cohorts | — | — | Endometrial Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HNF1A 31 / 181 cases (17 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PIK3R2 31 / 181 cases (17 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TET2 31 / 181 cases (17 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PRKDC 88 / 517 cases (17 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | APOB 87 / 517 cases (17 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH9 87 / 517 cases (17 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NBEA 87 / 517 cases (17 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Endometrial Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCDH15 87 / 517 cases (17 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UBR4 87 / 517 cases (17 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRV1 86 / 517 cases (17 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH2 86 / 517 cases (17 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH3 86 / 517 cases (17 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DYNC2H1 86 / 517 cases (17 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SACS 86 / 517 cases (17 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CARD11 30 / 181 cases (17 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GRIN2A 30 / 181 cases (17 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AGO2 28 / 169 cases (17 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SLX4 28 / 169 cases (17 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CHD3 85 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD2 85 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DCHS1 85 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MKI67 85 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Endometrial Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CEP290 84 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Endometrial Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DYNC1H1 84 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FCGBP 84 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC17 84 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NIPBL 84 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SZT2 84 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CTCF 305 / 1,882 cases (16 %) · ssm · ucec_ancestry_cds_msk_2023 · largest of 10 cohorts | — | — | Endometrial Carcinoma | 10 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRTM3 40 / 247 cases (16 %) · ssm · uec_cptac_gdc | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AKAP9 83 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BLTP1 83 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DOCK3 83 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Endometrial Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MGA 83 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Endometrial Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | USP9X 83 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AXIN2 29 / 181 cases (16 %) · ssm · ucec_ccr_msk_2022 | — | — | Endometrial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRG4 82 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TRRAP 82 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UTRN 82 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Endometrial Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PLEC 39 / 247 cases (16 %) · ssm · uec_cptac_gdc | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF469 39 / 247 cases (16 %) · ssm · uec_cptac_gdc | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CTNNB1 296 / 1,882 cases (16 %) · ssm · ucec_ancestry_cds_msk_2023 · largest of 9 cohorts | — | — | Endometrial Carcinoma | 9 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNHD1 81 / 517 cases (16 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Endometrial Carcinoma | 4 | Observed | cbioportal | graph → |